Association Analysis of Melanocortin 3 Receptor Polymorphisms with the Risk of Pulmonary Tuberculosis

Lung

Volumn 192, Issue 6, 2014, Pages 857-862

  Park, Byung Lae ^a   Kim, Lyoung Hyo ^a,b   Namgoong, Suhg ^a,b   Kim, Ji On ^a,b   Kim, Jason Yongha ^b   Chang, Hun Soo ^c   Park, Jong Sook ^c   Jang, An Soo ^c   Park, Sung Woo ^c   Kim, Do Jin ^c   Kim, Ki Up ^c   Kim, Yang Gee ^c   Uh, Soo Taek ^c   Seo, Ki Hyun ^c   Kim, Young Hoon ^c   Park, Choon Sik ^c   Shin, Hyoung Doo ^a,b  

^a SNP Genetics Inc   (South Korea)

^b Sogang University   (South Korea)

^c Soonchunhyang University   (South Korea)

Author keywords

Genetic factor; MC3R; Polymorphism; Pulmonary tuberculosis

Indexed keywords

MELANOCORTIN 3 RECEPTOR;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; CASE CONTROL STUDY; COHORT ANALYSIS; COMPARATIVE STUDY; FEMALE; GENE EXPRESSION REGULATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HUMAN; INCIDENCE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RISK; RISK ASSESSMENT; SEX RATIO; SOUTH KOREA; STATISTICAL MODEL; TUBERCULOSIS, PULMONARY; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INCIDENCE; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; POLYMORPHISM, GENETIC; RECEPTOR, MELANOCORTIN, TYPE 3; REPUBLIC OF KOREA; RISK ASSESSMENT; SEX DISTRIBUTION; TUBERCULOSIS, PULMONARY; YOUNG ADULT;

EID: 84937201920     PISSN: 03412040     EISSN: 14321750     Source Type: Journal    
DOI: 10.1007/s00408-014-9625-2     Document Type: Article

References (24)

1. Nunn P (2001) The global control of tuberculosis: what are the prospects? Scand J Infect Dis 33(5):329–332
2. Dye C, Scheele S, Dolin P, Pathania V, Raviglione MC (1999) Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA 282(7):677–686.
3. World Health Organization (2012). Global tuberculosis reports: epidemiology, pulmonary – prevention and control, economics, Directly observed therapy, Treatment outcome, National health programs – organization and administration, Statistics. WHO report
4. Casanova JL, Abel L (2002) Genetic dissection of immunity to mycobacteria: the human model. Annu Rev Immunol 20:581–620. doi:10.1146/annurev.immunol.20.081501.125851081501.125851
5. Comstock GW (1978) Tuberculosis in twins: a re-analysis of the prophit survey. Am Rev Respir Dis 117(4):621–624
6. Borgdorff MW (1998) The NRAMP1 gene and susceptibility to tuberculosis. N Engl J Med 339 (3):199–200; author reply 200-191. doi:10.1056/NEJM199807163390312
7. Shin HD, Park BL, Kim YH, Cheong HS, Lee IH, Park SK (2005) Common interleukin 10 polymorphism associated with decreased risk of tuberculosis. Exp Mol Med 37(2):128–132. doi:10.1038/emm.2005.17
8. Selvaraj P, Kurian SM, Chandra G, Reetha AM, Charles N, Narayanan PR (2004) Vitamin D receptor gene variants of BsmI, ApaI, TaqI, and FokI polymorphisms in spinal tuberculosis. Clin Genet 65(1):73–76. doi:10.1111/j.2004.00183.xCGE183
9. Shin HD, Cheong HS, Park BL, Kim LH, Han CS, Lee IH, Park SK (2008) Common MCL1 polymorphisms associated with risk of tuberculosis. BMB Rep 41(4):334–337
10. Adams LA, Moller M, Nebel A, Schreiber S, van der Merwe L, van Helden PD, Hoal EG (2011) Polymorphisms in MC3R promoter and CTSZ 3′UTR are associated with tuberculosis susceptibility. Eur J Hum Genet 19(6):676–681. doi:10.1038/ejhg.2011.1ejhg20111
11. Selvaraj P, Sriram U, Mathan Kurian S, Reetha AM, Narayanan PR (2001) Tumour necrosis factor alpha (−238 and −308) and beta gene polymorphisms in pulmonary tuberculosis: haplotype analysis with HLA-A, B and DR genes. Tuberculosis (Edinb) 81(5–6):335–341. doi:10.1054/tube.2001.0307S1472-9792(01)90307-5
12. Lee EJ, Lee SH, Jung JW, Lee W, Kim BJ, Park KW, Lim SK, Yoon CJ, Baik JH (2001) Differential regulation of cAMP-mediated gene transcription and ligand selectivity by MC3R and MC4R melanocortin receptors. Eur J Biochem 268(3):582–591.
13. Hruby VJ, Cai M, Cain JP, Mayorov AV, Dedek MM, Trivedi D (2007) Design, synthesis and biological evaluation of ligands selective for the melanocortin-3 receptor. Curr Top Med Chem 7(11):1107–1119
14. Tao YX (2010) Mutations in the melanocortin-3 receptor (MC3R) gene: impact on human obesity or adiposity. Curr Opin Investig Drugs 11(10):1092–1096
15. Livak KJ (1999) Allelic discrimination using fluorogenic probes and the 5′ nuclease assay. Genet Anal 14(5–6):143–149
16. Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21(2):263–265
17. Stephens M, Smith NJ, Donnelly P (2001) A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 68(4):978–989. doi:10.1086/319501
18. Nyholt DR (2004) A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. Am J Hum Genet 74(4):765–769. doi:10.1086/383251S0002-9297(07)61903-X
19. Cooke GS, Campbell SJ, Bennett S, Lienhardt C, McAdam KP, Sirugo G, Sow O, Gustafson P, Mwangulu F, van Helden P, Fine P, Hoal EG, Hill AV (2008) Mapping of a novel susceptibility locus suggests a role for MC3R and CTSZ in human tuberculosis. Am J Respir Crit Care Med 178(2):203–207. doi:10.1164/rccm.200710-1554OC200710-1554OC
20. Hashemi M, Eskandari-Nasab E, Moazeni-Roodi A, Naderi M, Sharifi-Mood B, Taheri M (2013) Association of CTSZ rs34069356 and MC3R rs6127698 gene polymorphisms with pulmonary tuberculosis. Int J Tuberc Lung Dis 17(9):1224–1228. doi:10.5588/ijtld.12.0762
21. Baker AR, Zalwango S, Malone LL, Igo RP Jr, Qiu F, Nsereko M, Adams MD, Supelak P, Mayanja-Kizza H, Boom WH, Stein CM (2011) Genetic susceptibility to tuberculosis associated with cathepsin Z haplotype in a Ugandan household contact study. Hum Immunol 72(5):426–430. doi:10.1016/j.humimm.2011.02.016
22. Eggert M, Pfob M, Steinlein OK (2013) Melanocortin-3-receptor promoter polymorphism associated with tuberculosis susceptibility does not influence protein expression. BMC Res Notes 6:99. doi:10.1186/1756-0500-6-991756-0500-6-99
23. Getting SJ, Gibbs L, Clark AJ, Flower RJ, Perretti M (1999) POMC gene-derived peptides activate melanocortin type 3 receptor on murine macrophages, suppress cytokine release, and inhibit neutrophil migration in acute experimental inflammation. J Immunol 162(12):7446–7453
24. Getting SJ, Di Filippo C, Christian HC, Lam CW, Rossi F, D’Amico M, Perretti M (2004) MC-3 receptor and the inflammatory mechanisms activated in acute myocardial infarct. J Leukoc Biol 76(4):845–853. doi:10.1189/jlb.0306175jlb.0306175